{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:20:22Z","timestamp":1783592422394,"version":"3.55.0"},"reference-count":25,"publisher":"Bioscientifica","issue":"8","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":211,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Small intestinal neuroendocrine tumors are often diagnosed at an advanced stage, with up to 70% of patients presenting with stage IV disease. While some guidelines recommend prophylactic resection of the primary tumor and mesenteric lymph node metastasis in patients without abdominal symptoms at diagnosis to prevent future abdominal complications, the benefit of this approach remains uncertain. This retrospective cohort study included 44 asymptomatic patients with stage IV small intestinal neuroendocrine tumors treated at Uppsala University Hospital between 2014 and 2019. Additional ten symptomatic patients who underwent at least two computed tomography scans before planned surgery were included in the analysis of mesenteric metastasis volume change and tumor growth rate. The primary outcomes were abdominal symptoms development requiring surgical intervention and the assessment of mesenteric metastasis size progression. During a 10-year follow-up, only four initially asymptomatic patients (9%) developed symptoms leading to surgery. Among all 54 patients, the median volume change in mesenteric metastases was \u2212298 mm3 (IQR: \u22122,785\u20131,294), with no significant difference between baseline and most recent scans (P = 0.38). The median interval between scans was 29 months, and the median tumor growth rate was \u22120.6% per month (IQR: \u22123.6\u20131.9%). Similar results were observed in the asymptomatic group. These findings suggest that a non-operative management in stage IV patients without abdominal symptoms is associated with a low incidence of symptom development and limited progression of mesenteric metastases.<\/jats:p>","DOI":"10.1530\/erc-25-0205","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:40:54Z","timestamp":1754394054000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":1,"title":["Locoregional progression and surgical indications in stage IV asymptomatic SI-NETs"],"prefix":"10.1530","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-4067","authenticated-orcid":true,"given":"Branislav","family":"Klim\u00e1cek","sequence":"first","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"\u00c5kerstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Anneb\u00e4ck","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hellman","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Welin","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Uppsala University 2 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundin","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olov","family":"Norl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"St\u00e5lberg","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2026070905452910500_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"key":"2026070905452910500_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2016.05.023","article-title":"Ileal \u201ccarcinoid\u201d tumors-small size belies deadly intent: high rate of nodal metastasis in tumors \u22641 cm in size","volume":"56","author":"Walsh","year":"2016","journal-title":"Hum Pathol"},{"key":"2026070905452910500_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","article-title":"The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society","volume":"46","author":"Howe","year":"2017","journal-title":"Pancreas"},{"key":"2026070905452910500_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","article-title":"Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors","volume":"154","author":"Zaidi","year":"2019","journal-title":"JAMA Surg"},{"key":"2026070905452910500_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center","volume":"36","author":"Norl\u00e9n","year":"2012","journal-title":"World J Surg"},{"key":"2026070905452910500_bib6","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1245\/s10434-015-4620-2","article-title":"Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis","volume":"22","author":"Pasquer","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2026070905452910500_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026070905452910500_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/ERC-17-0282","article-title":"Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours","volume":"25","author":"Bla\u017eevi\u0107","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026070905452910500_bib9","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/jcm9061777","article-title":"Pathogenesis and clinical management of mesenteric fibrosis in small intestinal neuroendocine neoplasms: a systematic review","volume":"9","author":"Koumarianou","year":"2020","journal-title":"J Clin Med"},{"key":"2026070905452910500_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11912-022-01211-5","article-title":"What causes desmoplastic reaction in small intestinal neuroendocrine neoplasms?","volume":"24","author":"Ratnayake","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"2026070905452910500_bib11","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026070905452910500_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"2026070905452910500_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070905452910500_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000471880","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: systemic therapy \u2013 biotherapy and novel targeted agents","volume":"105","author":"Pavel","year":"2017","journal-title":"Neuroendocrinology"},{"key":"2026070905452910500_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","article-title":"The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors","volume":"46","author":"Strosberg","year":"2017","journal-title":"Pancreas"},{"key":"2026070905452910500_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","article-title":"Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases","volume":"26","author":"Hellman","year":"2002","journal-title":"World J Surg"},{"key":"2026070905452910500_bib17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.surg.2006.07.033","article-title":"Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival","volume":"140","author":"Givi","year":"2006","journal-title":"Surgery"},{"key":"2026070905452910500_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1677\/ERC-09-0042","article-title":"Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study","volume":"16","author":"Ahmed","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"2026070905452910500_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jamaoncol.2017.3326","article-title":"Association of a prophylactic surgical approach to stage IV small intestinal neuroendocrine tumors with survival","volume":"4","author":"Daskalakis","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026070905452910500_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000464292","article-title":"ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: surgery for small intestinal and pancreatic neuroendocrine tumours","volume":"105","author":"Partelli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"2026070905452910500_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1078-0432.CCR-13-2098","article-title":"Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials","volume":"20","author":"Fert\u00e9","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2026070905452910500_bib22","doi-asserted-by":"crossref","first-page":"e1082","DOI":"10.1634\/theoncologist.2018-0672","article-title":"Value of tumor growth rate (TGR) as an early biomarker predictor of patients\u2019 outcome in neuroendocrine tumors (NET)-The GREPONET study","volume":"24","author":"Lamarca","year":"2019","journal-title":"Oncologist"},{"key":"2026070905452910500_bib23","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3390\/jcm9072319","article-title":"Surgery and perioperative management in small intestinal neuroendocrine tumors","volume":"9","author":"Deguelte","year":"2020","journal-title":"J Clin Med"},{"key":"2026070905452910500_bib25","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1097\/SLA.0000000000004647","article-title":"Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis","volume":"276","author":"Bennett","year":"2022","journal-title":"Ann Surg"},{"key":"2026070905452910500_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/cancers13030443","article-title":"Evolution of the mesenteric mass in small intestinal neuroendocrine tumours","volume":"13","author":"Bla\u017eevi\u0107","year":"2021","journal-title":"Cancers"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/8\/ERC-25-0205.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/8\/ERC-25-0205.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0205\/145270\/erc-25-0205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0205\/145270\/erc-25-0205.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:45:35Z","timestamp":1783590335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/8\/e250205\/25968\/Locoregional-progression-and-surgical-indications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0205","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"e250205"}}